 |
인쇄하기
취소
|
Three Korean firms’ March sales up 20 percent
The domestic industry’s top players - Dong-A Pharm, Yuhan Corporation and Chong Kun Dang Pharm – saw a steep hike in March sales on the back of their generic releases, according to market analysts.
Boosted by robust sales of flagship products such as Stillen and Opalmon, Dong-A recorded 36.4 percent in March sales. Yuhan and Chong Kun Dang posted 22.9 percent and 27.7 percent in sales growth...
Boosted by robust sales of flagship products such as Stillen and Opalmon, Dong-A recorded 36.4 percent in March sales. Yuhan and Chong Kun Dang posted 22.9 percent and 27.7 percent in sales growth...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.